RADIUS HEALTH, INC.: 10-Q filed 2013-11-14
What RADIUS HEALTH, INC. reported in its quarterly report filed 2013-11-14 (fiscal Q3 2013): 28 published measures, 82 facts as tagged in accession 0001104659-13-084867.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-11-14
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001104659-13-084867 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All RADIUS HEALTH, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 30,121,000 | USD | |
| At 2012-12-31 | 25,300,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -260,258,000 | USD | |
| At 2012-12-31 | -200,661,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 19,493,000 | USD | |
| At 2012-12-31 | 18,653,000 | USD | |
| At 2012-09-30 | 20,449,000 | USD | |
| At 2011-12-31 | 25,128,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -20,342,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -48,159,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -17,530,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -48,363,000 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -260,258,000 | USD | |
| At 2012-12-31 | -200,661,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 879,370 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 872,195 | shares | 273 |
| 2012-07-01 to 2012-09-30 | 859,769 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 830,068 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 879,370 | shares | 92 |
| 2013-01-01 to 2013-09-30 | 872,195 | shares | 273 |
| 2012-07-01 to 2012-09-30 | 859,769 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 830,068 | shares | 274 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -28.53 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | -69.77 | USD/shares | 273 |
| 2012-07-01 to 2012-09-30 | -24.53 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | -70.76 | USD/shares | 274 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -28.53 | USD/shares | 92 |
| 2013-01-01 to 2013-09-30 | -69.77 | USD/shares | 273 |
| 2012-07-01 to 2012-09-30 | -24.53 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | -70.76 | USD/shares | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 91,000 | USD | |
| At 2012-12-31 | 139,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 1,247,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 1,311,000 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -17,164,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -53,713,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -16,091,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -44,748,000 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 29,985,000 | USD | |
| At 2012-12-31 | 25,116,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 582,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 1,938,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 853,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 1,880,000 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 36,464,000 | USD | |
| At 2012-12-31 | 17,090,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 2,684,000 | USD | |
| At 2012-12-31 | 550,000 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 15,543,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 49,070,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 14,173,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 38,539,000 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 879,370 | shares | |
| At 2012-12-31 | 867,204 | shares |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 45,000 | USD | |
| At 2012-12-31 | 45,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 22,186,000 | USD | |
| At 2012-12-31 | 24,387,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 22,943,000 | USD | |
| At 2012-12-31 | 8,740,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 242,000 | USD | |
| At 2012-12-31 | 2,463,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -20,345,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -48,159,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -17,537,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -48,365,000 | USD | 274 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -25,090,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -60,857,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -21,090,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -58,733,000 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 1,621,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 4,643,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 1,918,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 6,209,000 | USD | 274 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 21,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 33,000 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -2,607,000 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 7,465,000 | USD | 273 |
| 2012-07-01 to 2012-09-30 | -604,000 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -1,788,000 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 2,134,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 549,000 | USD | 274 |
Inspect the source
- Entity
- RADIUS HEALTH, INC. / CIK 0001428522
- Captured
- SEC response SHA-256
2054192517bbc149217fd5b112e79d1fa1e935f422e730835ca8fbd528edd39e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001428522.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))